Company / Shareholders' Equity
Bio-Techne Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.9B
FY2025
5-year range
$1.6B / $2.1B
FY2021-FY2025
Trend
-7.3%
vs FY2024
Sector context
#56 of 161
Health Care
What the data says
At $1.9B, Bio-Techne's shareholders' equity ranks #56 of 161 in the Health Care sector. Declined from $2.0B to $1.9B over the past 2 years.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +6.8%.
Declined from $2.0B to $1.9B over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +4.1%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
#56 of 161 in Health CareTop 35% of 161This company $1.9B Sector average $5.1B
▼
-62.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 7.3% year-over-year.
- Ranks #56 out of 161 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | -7.3% |
| FY2024 | $2.1B | +5.2% |
| FY2023 | $2.0B | +15.6% |
| FY2022 | $1.7B | +8.9% |
| FY2021 | $1.6B | +13.2% |
| FY2020 | $1.4B | +18.5% |
| FY2019 | $1.2B | +8.0% |
| FY2018 | $1.1B | +13.6% |
| FY2017 | $949.6M | +8.0% |
| FY2016 | $879.3M | +3.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026